These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 19729434)

  • 61. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
    Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
    J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.
    You H; Gao T; Raup-Konsavage WM; Cooper TK; Bronson SK; Reeves WB; Awad AS
    Kidney Int; 2017 Mar; 91(3):671-682. PubMed ID: 27914709
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Discovery of genes related to diabetic nephropathy in various animal models by current techniques.
    Wada J; Sun L; Kanwar YS
    Contrib Nephrol; 2011; 169():161-174. PubMed ID: 21252517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Susceptible mice: identifying a diabetic nephropathy disease locus using a murine model.
    Brosius FC
    Kidney Int; 2010 Sep; 78(5):431-2. PubMed ID: 20706214
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Bradykinin B2 receptors as a target in diabetic nephropathy.
    Doggrell SA
    Curr Opin Investig Drugs; 2006 Mar; 7(3):251-5. PubMed ID: 16555685
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Piperazine ferulate ameliorates the development of diabetic nephropathy by regulating endothelial nitric oxide synthase.
    Yang YY; Shi LX; Li JH; Yao LY; Xiang DX
    Mol Med Rep; 2019 Mar; 19(3):2245-2253. PubMed ID: 30664213
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide.
    Goligorsky MS; Chen J; Brodsky S
    Hypertension; 2001 Feb; 37(2 Pt 2):744-8. PubMed ID: 11230367
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Translating experimental diabetic nephropathy studies from mice to men.
    Breyer MD
    Contrib Nephrol; 2011; 170():156-164. PubMed ID: 21659768
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
    Gangadharan Komala M; Gross S; Mudaliar H; Huang C; Pegg K; Mather A; Shen S; Pollock CA; Panchapakesan U
    PLoS One; 2014; 9(11):e108994. PubMed ID: 25369239
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ACE, PAI-1, decorin and Werner helicase genes are not associated with the development of renal disease in European patients with type 1 diabetes.
    De Cosmo S; Margaglione M; Tassi V; Garrubba M; Thomas S; Olivetti C; Piras GP; Trevisan R; Vedovato M; Cavallo Perin P; Bacci S; Colaizzo D; Cisternino C; Zucaro L; Di Minno G; Trischitta V; Viberti GC
    Diabetes Metab Res Rev; 1999; 15(4):247-53. PubMed ID: 10495473
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
    Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
    Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rodent models of streptozotocin-induced diabetic nephropathy.
    Tesch GH; Allen TJ
    Nephrology (Carlton); 2007 Jun; 12(3):261-6. PubMed ID: 17498121
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MafA-deficient and beta cell-specific MafK-overexpressing hybrid transgenic mice develop human-like severe diabetic nephropathy.
    Shimohata H; Yoh K; Fujita A; Morito N; Ojima M; Tanaka H; Hirayama K; Kobayashi M; Kudo T; Yamagata K; Takahashi S
    Biochem Biophys Res Commun; 2009 Nov; 389(2):235-40. PubMed ID: 19715672
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Urocortin ameliorates diabetic nephropathy in obese db/db mice.
    Li X; Hu J; Zhang R; Sun X; Zhang Q; Guan X; Chen J; Zhu Q; Li S
    Br J Pharmacol; 2008 Jul; 154(5):1025-34. PubMed ID: 18587447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
    El-Din Bessa SS; Hamdy SM
    Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
    [TBL] [Abstract][Full Text] [Related]  

  • 77. NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy.
    Du P; Fan B; Han H; Zhen J; Shang J; Wang X; Li X; Shi W; Tang W; Bao C; Wang Z; Zhang Y; Zhang B; Wei X; Yi F
    Kidney Int; 2013 Aug; 84(2):265-76. PubMed ID: 23594678
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 79. New targets for treatment of diabetic nephropathy: what we have learned from animal models.
    Brosius FC; Alpers CE
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):17-25. PubMed ID: 23207723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mouse models of diabetic nephropathy.
    Alpers CE; Hudkins KL
    Curr Opin Nephrol Hypertens; 2011 May; 20(3):278-84. PubMed ID: 21422926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.